To determine that Axl tyrosine kinase receptor is required to induce prostate cancer cells quiescent in bone marrow, SCID mice were intratibially injected with luciferase-labeled prostate cancer cell line (PC-3, DU145) that were either Axl-knockdown (sh Axl) or not (sh control). This evidence concerns the gene AXL and prostate cancer.